Aplidine for multiple myeloma treatment

Details for Australian Patent Application No. 2004218883 (hide)

Owner Dana-Farber Cancer Institute, Inc. Pharma Mar, S.A.

Inventors Faircloth, Glynn Thomas; Bertino, Joseph R.; Mitsiades, Nicholas; Anderson, Kenneth; Mitsiades, Constantine S.; Medina, Daniel

Agent Griffith Hack

Pub. Number AU-B-2004218883

PCT Pub. Number WO2004/080477

Priority 60/454,125 12.03.03 US; 60/520,293 14.11.03 US

Filing date 12 March 2004

Wipo publication date 23 September 2004

Acceptance publication date 1 October 2009

International Classifications

A61K 38/15 (2006.01) Medicinal preparations containing peptides - Depsipeptides

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/080477 Priority application(s): WO2004/080477

2 November 2006 Assignment before Grant

  Dana-Farber Cancer Institute, Inc.; Pharma Mar S.A. The application has been assigned to Dana-Farber Cancer Institute, Inc.; Pharma Mar, S.A.

1 October 2009 Application Accepted

  Published as AU-B-2004218883

28 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218891-Safety insert for single-use disposable syringes

2004218880-Treatment and/or prevention of nonviral epithelial damage